Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |